Ushbu ish iqtibos qilgan ishlar

164 ta ish

Ish: The Role of ΔFosB in the Pathogenesis of Levodopa-Induced Dyskinesia: Mechanisms and Therapeutic Strategies

1. Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression

   Elmira Roshani Asl, Mohammad Amini, Souzan Najafi +9

   Sharh maqola20215 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.267570

2. Parkinson's disease

   Bastiaan R. Bloem, Michael S. Okun, Christine Klein

   Sharh maqola20214 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.051760

3. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway

   Jae Hyeon Park, Jeremy D. Burgess, Ayman H. Faroqi +5

   Maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.110374

4. Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease: The Emerging Role of VDAC

   Pierpaolo Risiglione, Federica Zinghirino, Maria Carmela Di Rosa +2

   Sharh maqola20212 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.110384

5. Nitric oxide synthases: regulation and function

   Ulrich Förstermann, William C. Sessa

   Sharh maqola20112 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.196736

6. Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential

   Leski, Szymon, Lindén, Henrik, Tetzlaff, Tom +2

   Maqola20132 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.307366

7. ERK1/2 MAP kinases: Structure, function, and regulation

   Robert Roskoski

   Sharh maqola20122 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.307371

8. Autophagy: An Essential Degradation Program for Cellular Homeostasis and Life

   Yoomi Chun, Joungmok Kim

   Sharh maqola20182 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.307424

9. Mitochondrial Dysfunction and Mitophagy in Parkinson’s Disease: From Mechanism to Therapy

   Ana Belén Malpartida, Matthew G Williamson, Derek P. Narendra +2

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.307441

10. Amantadine treatment and delayed onset of levodopa‐induced dyskinesia in patients with early Parkinson's disease

    Chi‐Chuan Wang, Tsai‐Ling Wu, Fang‐Ju Lin +3

    Maqola20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307460

11. Molecular Mechanisms and Therapeutic Strategies for Levodopa-Induced Dyskinesia in Parkinson’s Disease: A Perspective Through Preclinical and Clinical Evidence

    Ritam Bandopadhyay, Nainshi Mishra, Ruhi Rana +7

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307465

12. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307325

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307326

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307327

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307328

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307329

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307330

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307331

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307332

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307333

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307334

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307335

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307336

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307337

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.307338